/

DXCM

DexCom, Inc.Closed

85.92+1.81 +2.15%USD

NasdaqGS · as of Oct 12, 16:00 ET · 15m delayAfter hours 85.92 0.00%

Open

84.73

Prev close

84.11

Day range

84.2186.10

52-week range

54.1192.59

Volume

2.89M0.65×

Mkt cap

32.42B

P/E ttm

34.79

Fwd P/E

27.48

EPS ttm

2.47

Div yield

0.00%

Earnings

Oct 29, 2026

From 52w high

−7.20%

Price Chart

Yahoo Finance · delayed

DXCMOct 12, 2026O 84.60H 86.10L 84.21C 85.92+1.81 (+2.15%)Vol 2.99M

SMA 5087.50
SMA 20073.60

1Y change +31.94% since Oct 10, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

DXCM DexCom, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −1.13%
1 month: +3.48%
3 months: +12.53%
6 months: +36.12%
Year to date: +29.46%
1 year: +31.94%

Valuation & ownership

Market cap: 32.42B
Enterprise value: 31.87B
P/E (ttm): 34.79
Forward P/E: 27.48
PEG ratio: 2.10
Price / book: 12.37
Price / sales (ttm): 6.52
EV / EBITDA: 22.71
EPS (ttm): 2.47
EPS (forward): 3.13
Beta (5y monthly): 1.48
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 377.36M
Float: 376.00M
Short % of float: 4.29%
Short ratio (days): 3.52
Held by insiders: 0.26%
Held by institutions: 106.68%
Avg volume (3m): 4.41M
50-day average: 87.50
200-day average: 73.60
52-week change: +31.94%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 49.5
vs 50-day SMA: −1.80%
vs 200-day SMA: +16.73%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 2.60%
Realised vol (20d, ann.): 23.3%
From 52-week high: −7.20%
From 52-week low: +58.79%

Signals (TECH)none at the last close

ANR

Analyst Consensus

26 analysts

Consensus

Strong buy

1.34 on a 1 (strong buy) – 5 (sell) scale

Mean target

96.23

+12.00% implied

Low 79.00Median 95.00High 115.00

Recommendation trend

Now26 / 3 / 0
1m ago / 3 /

DES

About DexCom, Inc.

Yahoo Finance profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Medical Devices
Employees: 11,000
Headquarters: San Diego, CA, United States
Website: dexcom.com
Officers: Mr. Kevin Ronald Sayer Executive Chairman of the Board
Mr. Jacob Steven Leach President, CEO & Director
Mr. Jereme M. Sylvain CPA Executive VP, CFO, COO & Chief Accounting Officer
Mr. Michael Jon Brown J.D. Executive VP, Chief Legal & Compliance Officer

SEAS

Seasonality · DXCM

2007–2026 · monthly returns

Strongest month Jun +8.69%Weakest month Sep −3.61%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	10.0	0.5	-14.5	-5.2	23.8	-8.7	23.9	9.1	-5.2	-0.4			+29.5%
2025	11.6	1.8	-22.7	4.5	20.2	1.7	-7.5	-6.7	-10.7	-13.5	9.0	4.6	−14.7%
2024	-2.2	-5.2	20.5	-8.2	-6.8	-4.5	-40.2	2.2	-3.3	5.1	10.7	-0.3	−37.3%
2023	-5.4	3.7	4.7	4.4	-3.4	9.6	-3.1	-18.9	-7.6	-4.8	30.0	7.4	+9.6%
2022	-19.8	-3.8	23.6	-20.1	-27.1	0.1	10.1	0.2	-2.0	50.0	-3.7	-2.6	−15.6%
2021	1.4	6.1	-9.7	7.4	-4.3	15.6	20.7	2.7	3.3	14.0	-9.7	-4.6	+45.2%
2020	10.1	14.6	-2.4	24.5	12.9	7.2	7.4	-2.3	-3.1	-22.5	0.0	15.7	+69.0%
2019	17.7	-1.2	-14.5	1.7	0.2	23.5	4.7	9.4	-13.0	3.4	47.4	-3.8	+82.6%
2018	1.4	-3.5	32.1	-1.3	20.2	7.9	0.2	51.8	-0.9	-7.2	-2.4	-7.6	+108.7%
2017	32.6	-1.3	8.4	-8.0	-14.3	9.4	-8.9	12.0	-34.4	-8.1	29.9	-1.8	−3.9%
2016	-13.0	-8.7	4.4	-5.2	0.2	23.0	16.3	-1.2	-3.8	-10.7	-16.6	-8.6	−27.1%
2015	8.6	1.6	2.6	8.4	6.1	11.5	5.8	11.2	-8.8	-3.0	2.0	-3.7	+48.8%
2014	14.3	11.5	-8.3	-21.6	4.1	17.5	-5.0	17.3	-9.5	12.4	14.5	7.0	+55.5%
2013	12.1	-2.0	12.1	-1.9	26.9	7.8	-3.0	24.2	4.3	1.8	15.2	7.0	+160.6%
2012	17.8	-1.6	-3.3	-6.2	10.0	20.4	-15.0	20.8	13.0	-12.8	-0.2	3.9	+46.0%
2011	3.4	3.7	6.1	7.3	-5.3	-8.1	-2.1	-15.2	-0.2	-18.4	-18.1	16.1	−31.8%
2010	12.3	-0.2	7.7	12.4	-3.8	9.8	-3.5	9.6	8.1	4.3	-18.2	21.0	+69.1%
2009	17.0	25.4	2.2	8.2	24.1	11.3	4.4	20.9	1.5	-13.5	5.7	11.3	+192.4%
2008	-4.8	-12.4	-43.8	86.0	2.5	-23.4	11.3	2.4	-10.0	-27.0	-55.8	38.0	−68.7%
2007	-9.7	-9.1	-2.8	1.4	-17.7	24.8	-2.0	14.6	8.7	-7.0	-7.0	2.1	−10.4%

INSD

Insider Activity · DXCM

Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

80.4K shares

Sells, 6 months

153.9K shares

Net shares

−73.5K

Net change in insider shares

−6.90%

Date	Insider	Transaction	Shares	Value
Sep 27, 2026	Stern SadieOfficer	Sale at price 86.15 per share.	2.6K	$220.97K
Sep 14, 2026	Brown Michael JonOfficer	Sale at price 84.04 per share.	1.7K	$142.87K
Sep 14, 2026	Augustinos NicholasDirector	Sale at price 84.02 - 84.04 per share.	8.1K	$679.77K
Sep 9, 2026	Sylvain Jereme MChief Financial Officer	Sale at price 83.27 per share.	3.6K	$302.94K
Sep 9, 2026	Boehnlein Glenn SDirector	Stock Award(Grant) at price 0.00 per share.	5.8K	—
Aug 26, 2026	Stern SadieOfficer	Sale at price 88.37 per share.	2.6K	$226.67K
Aug 19, 2026	Sayer Kevin ROfficer and Director	Sale at price 89.71 - 91.41 per share.	26.8K	$2.41M
Aug 13, 2026	Brown Michael JonOfficer	Sale at price 91.93 per share.	1.7K	$156.28K
Aug 11, 2026	Augustinos NicholasDirector	Stock Gift at price 0.00 per share.	1.1K	—
Aug 11, 2026	Heller Bridgette PDirector	Sale at price 88.29 per share.	1K	$89.35K
Aug 2, 2026	Foletta Mark GDirector	Sale at price 80.00 - 85.32 per share.	4K	$330.64K
Jul 19, 2026	Sayer Kevin ROfficer and Director	Sale at price 76.32 per share.	26.8K	$2.04M
Jul 14, 2026	Brown Michael JonOfficer	Sale at price 74.42 per share.	1.7K	$126.51K
Jul 5, 2026	Sayer Kevin ROfficer and Director	Sale at price 72.00 per share.	26.8K	$1.93M
Jun 14, 2026	Brown Michael JonOfficer	Sale at price 75.55 per share.	1.7K	$128.44K
Jun 14, 2026	Foletta Mark GDirector	Sale at price 74.10 - 74.82 per share.	4K	$296.54K
Jun 3, 2026	Coleman JonOfficer	Sale at price 73.00 - 74.13 per share.	9.8K	$722.63K
May 27, 2026	Collins Richard AlexanderDirector	Stock Award(Grant) at price 0.00 per share.	5.6K	—
May 27, 2026	Malady KyleDirector	Stock Award(Grant) at price 0.00 per share.	5.6K	—
May 27, 2026	Gala Renee DDirector	Stock Award(Grant) at price 0.00 per share.	5.6K	—

CONG

Congress Trades · DXCM

House reports since 2025

Members

1 last bought

Buys

~$48.5K

Sells

~$148.0K

Net

−$99.5K

est. bought − sold

Latest

May 15, 25

Rob Bresnahan

Members who traded it

Member	Buys	Sells	Est. net	Last move
Rob Bresnahan PA08	2	1	+$8.0K	Bought May 15, 25
Jefferson Shreve IN06	1	2	−$32.5K	Sold May 12, 25
Kevin Hern OK01		1	−$75.0K	Sold Dec 31, 24

Bought and sold by quarter (est.)

House members' DXCM trades, newest first
Traded	Member	Owner	Type	Amount	Filed	Report
May 15, 25	Rob Bresnahan PA08	Self	Buy	$1,001 - $15,000	Jun 9, 25 (25d)	PDF
May 12, 25	Jefferson Shreve IN06	Self	Sell	$15,001 - $50,000	Jun 22, 25 (41d)	PDF
May 8, 25	Jefferson Shreve IN06	Self	Buy	$15,001 - $50,000	Jun 22, 25 (45d)	PDF
Apr 8, 25	Rob Bresnahan PA08	Self	Sell	$1,001 - $15,000	Apr 28, 25 (20d)	PDF
Apr 7, 25	Jefferson Shreve IN06	Self	Sell	$15,001 - $50,000	May 8, 25 (31d)	PDF
Feb 25, 25	Rob Bresnahan PA08	Self	Buy	$1,001 - $15,000	Mar 27, 25 (30d)	PDF
Dec 31, 24	Kevin Hern OK01	Joint	Sell	$50,001 - $100,000	Jan 15, 25 (15d)	PDF

From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades

DXCM

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

DXCM

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About DexCom, Inc.

Seasonality · DXCM

Insider Activity · DXCM

Congress Trades · DXCM

Members who traded it

Bought and sold by quarter (est.)

Congress Trades · DXCM

Members who traded it

Bought and sold by quarter (est.)

Insider Activity · DXCM

Seasonality · DXCM

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About DexCom, Inc.

Financial Snapshot

Earnings & Dividends

News